Comparative Study
doi: 10.1016/j.bmcl.2009.12.014.
Epub 2009 Dec 6.
Tricyclic dihydroquinazolinones as novel 5-HT2C selective and orally efficacious anti-obesity agents
Affiliations
- PMID: 20022752
- DOI: 10.1016/j.bmcl.2009.12.014
Item in Clipboard
Comparative Study
Tricyclic dihydroquinazolinones as novel 5-HT2C selective and orally efficacious anti-obesity agents
Bioorg Med Chem Lett.
.
Abstract
Agonists of the 5-HT(2C) receptor have been shown to suppress appetite and reduce body weight in animal models as well as in humans. However, agonism of the related 5-HT(2B) receptor has been associated with valvular heart disease. Synthesis and biological evaluation of a series of novel and highly selective dihydroquinazolinone-derived 5-HT(2C) agonists with no detectable agonism of the 5-HT(2B) receptor is described. Among these, compounds (+)-2a and (+)-3c were identified as potent and highly selective agonists which exhibited weight loss in a rat model upon oral dosing.
Copyright (c) 2009 Elsevier Ltd. All rights reserved.
Similar articles
-
Discovery and SAR of new benzazepines as potent and selective 5-HT(2C) receptor agonists for the treatment of obesity.Bioorg Med Chem Lett. 2005 Mar 1;15(5):1467-70. doi: 10.1016/j.bmcl.2004.12.080. Bioorg Med Chem Lett. 2005. PMID: 15713408
-
Design and synthesis of orally-active and selective azaindane 5HT2c agonist for the treatment of obesity.Bioorg Med Chem Lett. 2010 Jan 1;20(1):266-71. doi: 10.1016/j.bmcl.2009.10.112. Epub 2009 Oct 30. Bioorg Med Chem Lett. 2010. PMID: 19914063
-
Discovery and structure-activity relationship of (1R)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a selective serotonin 5-HT2C receptor agonist for the treatment of obesity.J Med Chem. 2008 Jan 24;51(2):305-13. doi: 10.1021/jm0709034. Epub 2007 Dec 21. J Med Chem. 2008. PMID: 18095642
-
Serotonin 5-ht2c receptor agonists: potential for the treatment of obesity.Mol Interv. 2005 Oct;5(5):282-91. doi: 10.1124/mi.5.5.8. Mol Interv. 2005. PMID: 16249524 Review.
-
Agonists of the serotonin 5-HT2C receptor: preclinical and clinical progression in multiple diseases.Curr Opin Drug Discov Devel. 2008 Jul;11(4):438-45. Curr Opin Drug Discov Devel. 2008. PMID: 18600561 Review.
Cited by
-
Identification of Optically Active Pyrimidine Derivatives as Selective 5-HT2C Modulators.Molecules. 2017 Aug 26;22(9):1416. doi: 10.3390/molecules22091416. Molecules. 2017. PMID: 28846591 Free PMC article.
-
Diversity oriented synthesis and IKK inhibition of aminobenzimidazole tethered quinazoline-2,4-diones, thioxoquinazolin-4-ones, benzodiazepine-2,3,5-triones, isoxazoles and isoxazolines.Bioorg Med Chem Lett. 2015 Feb 1;25(3):685-9. doi: 10.1016/j.bmcl.2014.11.078. Epub 2014 Dec 8. Bioorg Med Chem Lett. 2015. PMID: 25522820 Free PMC article.
-
HTS and rational drug design to generate a class of 5-HT(2C)-selective ligands for possible use in schizophrenia.ChemMedChem. 2010 Aug 2;5(8):1221-5. doi: 10.1002/cmdc.201000186. ChemMedChem. 2010. PMID: 20533502 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Medical
